Breaking News
April 21, 2019 - More TV, Tablets, More Attention Issues at Age 5
April 21, 2019 - Drug reduces risk of kidney failure in people with diabetes, study finds
April 21, 2019 - New research identifies novel link between antibiotic resistance and climate change
April 21, 2019 - Simple intervention can provide lasting protection for teens against junk food marketing
April 21, 2019 - The protein p38-gamma identified as a new therapeutic target in liver cancer
April 21, 2019 - Novel system enables researchers to study bacteria within mini-tissues in a dish
April 21, 2019 - Discovery of oral cancer biomarkers could save thousands of lives
April 21, 2019 - Geneva Exhibition committee gives gold medals to two medications developed by Kazan
April 21, 2019 - Scientists aim to minimize or eliminate hair loss during cancer treatment
April 21, 2019 - WiFi interacts with signaling pathways in the human brain
April 21, 2019 - Stroke Hospitalizations Down in Black, White Medicare Enrollees
April 21, 2019 - First common risk genes discovered for autism
April 21, 2019 - Researchers map auditory sensory system of the mouse brain
April 21, 2019 - Scientists Bring Pig’s Brain, Dead 4 Hours, Back to ‘Cellular Activity’
April 21, 2019 - Virtual reality a promising tool for reducing fears and phobia in autism
April 21, 2019 - New analysis lists out opportunities for U.S. medical schools to advance population health
April 21, 2019 - More sleep may help teens with ADHD focus and organize
April 21, 2019 - Breakthrough antibody treatment suppresses HIV without antivirals
April 21, 2019 - AveXis Data Reinforce Effectiveness of Zolgensma in Treating Spinal Muscular Atrophy (SMA) Type 1
April 21, 2019 - Is your hand pain arthritis, carpal tunnel or something else?
April 21, 2019 - Measles outbreaks may become more frequent if vaccination rates continue to decline
April 21, 2019 - Researchers succeed in accelerating process of creating 3D images
April 21, 2019 - Tiny worm mimics key genetic risk for Alzheimer’s
April 21, 2019 - Angry dreams explained by brain waves
April 20, 2019 - Parenteral Antimicrobial Tx at Home Burdens Children’s Caregivers
April 20, 2019 - Diabetes treatment may keep dementia, Alzheimer’s at bay
April 20, 2019 - New bandage-like biosensor collects and analyzes sweat
April 20, 2019 - A comprehensive, centralized database of bovine milk compounds
April 20, 2019 - Two new epigenetic regulators maintain self-renewal of embryonic stem cells
April 20, 2019 - New Evidence That Veggies Beat Steak for Heart Health
April 20, 2019 - Study reveals genes associated with heavy drinking and alcoholism
April 20, 2019 - Texas A&M AgriLife becomes the newest member of NutriRECS international consortium
April 20, 2019 - In most states, insurance won’t cover addiction treatments
April 20, 2019 - Computer-based memory games may be beneficial for individuals with fragile X syndrome
April 20, 2019 - Timing of food intake influences molecular clock in the liver of mice
April 20, 2019 - Precise decoding of breast cancer cells paves way for new treatment option
April 20, 2019 - Scientists use 3D imaging to help model complex processes performed by placenta
April 20, 2019 - MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS
April 20, 2019 - Genetic variants that protect against obesity could aid new weight loss medicines
April 20, 2019 - New technology developed for microscopic imaging in living organisms
April 20, 2019 - when quitting cigarettes, consider using more nicotine, not less
April 20, 2019 - Key proteins can block Listeria without triggering the death of host cells
April 20, 2019 - Researchers create a working model of cerebral tract to study brain function
April 20, 2019 - New study shows that microbes can help break toxic chemical in dust
April 20, 2019 - Scientists use NIR light and injected DNA nanodevice to guide stem cells to injury
April 20, 2019 - Microbial Features ID’d for Pediatric Irritable Bowel Syndrome
April 20, 2019 - Study reveals patterns of drug intoxication deaths, organ donors across the US
April 20, 2019 - Scientists deploy CRISPR gene-editing tool to engineer multiple edits
April 20, 2019 - AHA News: Here’s How Middle-Aged People — Especially Women — Can Avoid a Heart Attack
April 20, 2019 - Charcot foot: MedlinePlus Medical Encyclopedia
April 20, 2019 - France to ban popular breast implants over cancer risk: media
April 20, 2019 - Researchers explore whether time of day can affect the body’s response to physical exertion
April 20, 2019 - CPAP brings longer life for obese people with sleep apnea: Study
April 20, 2019 - New discovery transforms conventional microfluidics into open-space microfluidics
April 20, 2019 - An accurate estimation of the overall cost of bacterial resistance in French hospitals during 2015 and 2016
April 20, 2019 - ‘PRO-cision Medicine’ approach helps personalize care for patients with cancer
April 19, 2019 - TG Therapeutics Receives Orphan Drug Designation for Umbralisib from the U.S. Food and Drug Administration for the Treatment of Marginal Zone Lymphoma
April 19, 2019 - Screen time—even before bed—has little impact on teen well-being: study
April 19, 2019 - Cytosurge’s first FluidFM User Conference
April 19, 2019 - New study finds that previously described differences among endoscopists are not true
April 19, 2019 - Study compares effectiveness and cost of gene therapy and HSCT in major beta-thalassemia
April 19, 2019 - Scientific breakthrough provides new hope for people living with multiple sclerosis
April 19, 2019 - New Virtual Reality Therapy game could offer relief for patients with chronic pain, mobility issues
April 19, 2019 - Emergency medicine doctors find better way to treat severe epileptic seizures in children
April 19, 2019 - MedlinePlus: Cholesterol Good and Bad
April 19, 2019 - For busy medical students, two-hour meditation study may be as beneficial as longer course
April 19, 2019 - Music therapy helps young patients feel better
April 19, 2019 - Molecular target UNC45A is essential for cancer cell proliferation and tumor growth
April 19, 2019 - Crackling and wheezing could be the sounds of a progressing lung disease
April 19, 2019 - Key research takeaways from ECCMID 2019
April 19, 2019 - AI Can Identify Model of Cardiac Rhythm Device From Chest X-Ray
April 19, 2019 - New way to combat childhood anxiety: treat the parents
April 19, 2019 - Women getting C-sections best judge of own pain medication needs | News Center
April 19, 2019 - Light-intensity physical activity associated with healthy brain aging
April 19, 2019 - Immune responses that prevent fungal infections may eliminate Trichinella spiralis
April 19, 2019 - Exercising in the morning, rather than at night, may yield better results, shows study
April 19, 2019 - Why eating ‘right’ could cause you to stray from your diet
April 19, 2019 - Health Tip: Antidepressant Precautions – Drugs.com MedNews
April 19, 2019 - Bigger portions lead to preschoolers eating more over time
April 19, 2019 - Specific strains of Staphylococcus aureus linked to wounds that do not heal
Overlooked immune cells could play a key role in cancer immunotherapy, claims new study

Overlooked immune cells could play a key role in cancer immunotherapy, claims new study

image_pdfDownload PDFimage_print

Cancer immunotherapy is an attractive and relatively newer method of treating cancer by enhancing the combat-readiness of the host immune system against cancer cells. It has succeeded with some refractory tumors. However, it doesn’t always work, and the question remains, why not?

CI Photos | Shutterstock

Researchers in this field have mostly examined the role played by CD8+ cells, a type of T lymphocyte which recognizes and eliminates cells in the body on which cancer antigens are found. A cancer antigen is an abnormal protein formed from a mutated gene.

In this process, the contribution of CD4+ T cells to the fight against cancer antigens was overlooked, but these cells have gained new importance following the publication of a study in Cell, on September 20.

The new study revolves around a bioinformatics-centered analysis of the Major Histocompatibility Complex (MHC), a molecular family found prominently on the surface of most of the cells in the body. There are two types of MHC molecules, namely, MHC-I and MHC-II.

These are concerned with presenting antigenic molecules from every type of antigen within the cell, whether belonging to the cell or not. Only then can these antigens be recognized by patrolling T cells. If they are “self” antigens, the T cells do not react to them. However, if the antigens are “foreign”, either from viruses, bacteria or oncoproteins, instant T cell-mediated killing of the infected or tumorous cell occurs.

MHC-I molecules are found on all cell surfaces. MHC-II molecules are found only on the surface of immune cells, like macrophages. These molecules are both more complex and able to bind antigens of a greater variety than can MHC-I molecules. The MHC-I and MHC-II molecules thus complement each other, making it less likely that a mutated cell will escape both systems.

The more we know about the ability of a person’s immune system to clear cancer cells before they take hold, and the more we can combine that with other information about their inherited risk factors or environmental exposures, the better we may get at predicting a person’s cancer susceptibility.”

Study leader and senior author Hannah Carter, PhD, assistant professor of medicine at UC San Diego School of Medicine.

An older study by the same authors published in Cell had already revealed that a cancer antigen bound by an MHC-I molecule was unlikely to surface later in any tumor developed by that individual. This is because any antigen presented by the MHC-I system leads to the immediate elimination of that cell.

Conversely, if the MHC-I molecules cannot present a particular antigen, it escapes surveillance and may eventually be found in a tumor in that individual. The less the number of cancer antigens recognized by the MHC-I system, the higher is the individual’s risk of developing cancer at an earlier age.

This type of research could ultimately help to predict which type of cancer a person is at risk for, the probable tumor behavior and the potentially useful treatment methods, even before a tumor develops.

The current study focused on the specific importance of MHC-II in immune cancer surveillance. Using computational biology, researchers analyzed data obtained from The Cancer Genome Atlas (TCGA), which is a database set up by the National Institutes of Health containing information on the genomes of thousands of human tumors of many types.

They retrieved data on the MHC-II antigen-presenting capability for 1018 cancer antigens, in 5942 tumors, scoring the tumors accordingly. As expected, antigens recognized by a person’s MHC-II molecules were unlikely to be present in a tumor developing in that individual, and vice versa. This association was similar to that observed for MHC-I tumor antigen recognition, but even stronger.

The surprise was finding that unlike MHC-I antigen recognition, the number of cancer antigens presented by the MHC-II system does not affect the age at which cancer eventually develops, at least according to this very early study.

More research is needed, because MHC-II molecules are more complex and recognize a wider range of antigens. More advanced tools are also required. However, the authors hope to see increased interest in evolving personalized cancer immunotherapy based on both MHC-I and MHC-II antigen recognition data.

For instance, readouts of MHC-I and MHC-II antigen presenting profiles could explain why patients respond differently to the same immunotherapy, or help predict the individual’s reaction to treatment. This can avoid the use of ineffective therapies, and thus bring down the rate of potentially serious adverse reactions.  

Bringing MHC into the big picture of cancer through genomic analysis is a powerful new way to integrate the master regulator of immunity into a better understanding of cancer evolution and its dynamic interplay with the immune system. This may represent a step forward in our ability to select the best form of immunotherapy for individual patients and likewise help better predict response to immunotherapy. I see this work as a major step to bridge cancer genomics and cancer immunity.”

Maurizio Zanetti, MD, study co-author, who is professor of medicine at UC San Diego School of Medicine and head of the Laboratory of Immunology at Moores Cancer Center.

Source:

https://www.eurekalert.org/pub_releases/2018-09/uoc–cim092018.php

Tagged with:

About author

Related Articles